  |
Items where Author is "Flaberg, E."
Group by: Item Type | No Grouping Number of items: 6. Markasz, L. and Vanherberghen, B. and Flaberg, E. and Otvos, R. and Stuber, G. and Oláh, Éva (2009) NK cell-mediated lysis is essential to kill Epstein-Barr virus transformed lymphoblastoid B cells when using rituximab. BIOMEDICINE & PHARMACOTHERAPY, 63. pp. 413-420. ISSN 0753-3322 Markasz, L. and Skribek, H. and Uhlin, M. and Otvos, R. and Flaberg, E. and Oláh, Éva (2008) Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes. JOURNAL OF IMMUNOTHERAPY, 31 (3). pp. 283-293. ISSN 1524-9557 Markasz, L. and Stuber, G. and Flaberg, E. and Jernberg, A. G. and Eksborg, S. and Oláh, Éva (2007) Cytotoxic drug sensitivity of epstein-barr virus transformed lymphoblastoid b-cells. BLOOD REVIEWS, 21 (Supl 1). S98-S99. ISSN 0268-960X Markasz, L. and Stuber, G. and Vanherberghen, B. and Flaberg, E. and Oláh, Éva (2007) Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells. MOLECULAR CANCER THERAPEUTICS, 6 (2). pp. 644-654. ISSN 1535-7163 Markasz, L. and Kis, L. L. and Stuber, Gy. and Flaberg, E. and Otvos, R. and Oláh, Éva and Székely, László (2007) Hodgkin-lymphoma-derived cells show high sensitivity to dactinomycin and paclitaxel. LEUKEMIA AND LYMPHOMA, 48 (9). pp. 1835-1845. ISSN 1042-8194 Markasz, L. and Stuber, Gy. and Flaberg, E. and Jernberg, A. G. and Eksborg, S. and Oláh, Éva (2006) Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells. BMC CANCER, 6. pp. 1-12. ISSN 1471-2407 |
